ArticleJournal of clinical neurology (Seoul, Korea)2019

Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up.

Jae Won Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.